Helicobacter Pylori Related Gastric Cancer Screening and Cost-Effectiveness Analysis: A Hospital-Based Cross-Sectional Study (SIGES)

References

• Cavatorta O, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De’ Angelis GL, Di Mario F. Epidemiology of gastric cancer and risk factors. Acta Biomed. 2018;89(8-s):82–7.
   PubMedGoogle Scholar
• Wang R, Chen XZ. High mortality from hepatic, gastric and esophageal cancers in mainland China: 40 years of experience and development. Clin Res Hepatol Gastroenterol. 2014;38(6):751–6. doi:https://doi.org/10.1016/j.clinre.2014.04.014
   PubMedGoogle Scholar
• Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58. doi:https://doi.org/10.1016/S0140-6736(19)30427-1
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen H, Yin X, He Q, Man J, Yang X, Lu M. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: findings from global burden of disease study. Chin J Cancer Res. 2021;33(1):11–26. doi:https://doi.org/10.21147/j.issn.1000-9604.2021.01.02
   PubMed Web of Science ®Google Scholar
• The global, regional, and national burden of stomach cancer in 195 countries. 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 1990;5(1):42–54.
   Google Scholar
• Suzuki H, Oda I, Abe S, Sekiguchi M, Mori G, Nonaka S, Yoshinaga S, Saito Y. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198–205. doi:https://doi.org/10.1007/s10120-015-0469-0
   PubMed Web of Science ®Google Scholar
• Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, Katai H, Tsujitani S, Kodera Y, Seto Y, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14(4):301–16. doi:https://doi.org/10.1007/s10120-011-0085-6
   PubMed Web of Science ®Google Scholar
• Goto R, Hamashima C, Mun S, Lee W-C. Why screening rates vary between Korea and Japan-differences between two national healthcare systems. Asian Pac J Cancer Prev. 2015;16(2):395–400. doi:https://doi.org/10.7314/apjcp.2015.16.2.395
   PubMedGoogle Scholar
• Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X, Li H, Li Q, Wang N, Ji J, et al. Gastric cancer: epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32(6):695–704. doi:https://doi.org/10.21147/j.issn.1000-9604.2020.06.03
   PubMed Web of Science ®Google Scholar
• Trédaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997;72(4):565–73. doi:https://doi.org/10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O
   PubMed Web of Science ®Google Scholar
• Woo HD, Park S, Oh K, Kim HJ, Shin HR, Moon HK, Kim J. Diet and cancer risk in the Korean population: a meta-analysis. Asian Pac J Cancer Prev. 2014;15(19):8509–19. doi:https://doi.org/10.7314/apjcp.2014.15.19.8509
   PubMedGoogle Scholar
• Yang G-H, Li Q, Wang C-X, Hsia J, Yang Y, Xiao L, Yang J, Zhao L-H, Zhang J, Xie L, et al. Findings from 2010 Global Adult Tobacco Survey: implementation of MPOWER policy in China. Biomed Environ Sci. 2010;23(6):422–9. doi:https://doi.org/10.1016/S0895-3988(11)60002-0
   PubMed Web of Science ®Google Scholar
• Guo H, Quan G. Tobacco control in China and the road to Healthy China 2030. Int J Tuberc Lung Dis. 2020;24(3):271–7. doi:https://doi.org/10.5588/ijtld.19.0106
   PubMed Web of Science ®Google Scholar
• Wang S-S, Lay S, Yu H-N, Shen S-R. Dietary guidelines for Chinese residents (2016): comments and comparisons. J Zhejiang Univ Sci B. 2016;17(9):649–56. doi:https://doi.org/10.1631/jzus.B1600341
   PubMed Web of Science ®Google Scholar
• Zeng H, Sun K, Cao M, Zheng R, Sun X, Liu S, Zhang Z, Liu Y, Guo G, Song G, et al. Initial results from a multi-center population-based cluster randomized trial of esophageal and gastric cancer screening in China. BMC Gastroenterol. 2020;20(1):398. doi:https://doi.org/10.1186/s12876-020-01517-3
   PubMedGoogle Scholar
• Ji L, Liu Z, Zhou B, Cai Y, An F, Wang L, Lv Z, Xia M, Yang J, Yuan J, et al. Community-based pilot study of a screening program for gastric cancer in a Chinese population. Cancer Prev Res (Phila). 2020;13(1):73–82. doi:https://doi.org/10.1158/1940-6207.CAPR-19-0372
   PubMedGoogle Scholar
• Lü YL, et al. Comparison of two gastric cancer screening schemes in a high-risk population. Zhonghua Zhong Liu Za Zhi. 2013;35(5):394–7.
   PubMedGoogle Scholar
• Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, Li J, Zhang K, Ye G, Ye L, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–87. doi:https://doi.org/10.1136/gutjnl-2018-317556
   PubMed Web of Science ®Google Scholar
• Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4(6):709–16. doi:https://doi.org/10.1016/j.cgh.2006.03.025
   PubMed Web of Science ®Google Scholar
• Chen XZ, Zhang WH, Hu JK. A difficulty in improving population survival outcome of gastric cancer in mainland China: low proportion of early diseases. Med Oncol. 2014;31(12):315. doi:https://doi.org/10.1007/s12032-014-0315-y
   PubMedGoogle Scholar
• Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW. Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol. 2014;21(9):3008–14. doi:https://doi.org/10.1245/s10434-014-3664-z
   PubMedGoogle Scholar
• Eghdami A, Ostovar R, Jafari A, Palmer AJ, Bordbar N, Ravangard R. Economic burden of gastric cancer: a case of Iran. Cancer Control. 2019;26(1):1073274819837185. doi:https://doi.org/10.1177/1073274819837185
   Google Scholar
• Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
   PubMedGoogle Scholar
• Leja M, Axon A, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016; 21(Suppl 1):3–7. doi:https://doi.org/10.1111/hel.12332
   PubMedGoogle Scholar
• Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9. doi:https://doi.org/10.1053/j.gastro.2017.04.022
   PubMed Web of Science ®Google Scholar
• Tang HR, Fan YJ, Liu S. Helicobacter pylori infection and associated risk factors in Chengdu. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014;45(5):823–6.
   PubMedGoogle Scholar
• Waldum HL, Kleveland PM, Sørdal Ø F. Helicobacter pylori and gastric acid: an intimate and reciprocal relationship. Therap Adv Gastroenterol. 2016;9(6):836–44. doi:https://doi.org/10.1177/1756283X16663395
   PubMedGoogle Scholar
• Chen X-Z, Schöttker B, Castro FA, Chen H, Zhang Y, Holleczek B, Brenner H. Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: a ten-year follow-up of the ESTHER cohort study. Oncotarget. 2016;7(13):17182–93. doi:https://doi.org/10.18632/oncotarget.7946
   PubMedGoogle Scholar
• Wang R, Bai D, Xiang W, Zhang Y-F, Ba K-Y, Chen X-Z, SIGES Research Group. Helicobacter pylori prevalence in the Southwest of China: a protocol for systematic review. Medicine (Baltimore). 2020;99(11):e19369. doi:https://doi.org/10.1097/MD.0000000000019369
   PubMedGoogle Scholar
• Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014;20(38):13842–62. doi:https://doi.org/10.3748/wjg.v20.i38.13842
   PubMed Web of Science ®Google Scholar
• Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol. 2013;27(6):933–47. doi:https://doi.org/10.1016/j.bpg.2013.09.005
   PubMedGoogle Scholar
• Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, European Helicobacter and Microbiota Study Group and Consensus panel, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30. doi:https://doi.org/10.1136/gutjnl-2016-312288
   PubMed Web of Science ®Google Scholar
• Wang R, et al. Risk population of Helicobacter pylori infection among Han and Tibetan ethnicities in western China: a cross-sectional, longitudinal epidemiological study. Lancet. 2016;388:17.
   Google Scholar
• Chen X-Z, Zhang W-H, Yang K, Zhang B, Chen Z-X, Chen J-P, Zhou Z-G, Hu J-K. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population. Tumour Biol. 2014;35(9):9015–22. doi:https://doi.org/10.1007/s13277-014-1986-x
   PubMedGoogle Scholar
• Wang R, Chen XZ. Prevalence of atrophic gastritis in southwest China and predictive strength of serum gastrin-17: a cross-sectional study (SIGES). Sci Rep. 2020;10(1):4523. doi:https://doi.org/10.1038/s41598-020-61472-7
   PubMedGoogle Scholar
• Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345(2):196–202. doi:https://doi.org/10.1016/j.canlet.2013.08.016
   PubMed Web of Science ®Google Scholar
• Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J, Xing X, Wang J, Du Z, Misumi J, et al. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer. 2012;130(7):1614–9. doi:https://doi.org/10.1002/ijc.26172
   PubMedGoogle Scholar
• Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet. 1996;348(9021):150–4. doi:https://doi.org/10.1016/S0140-6736(96)01501-2
   PubMed Web of Science ®Google Scholar
• Lee Y-C, Wu H-M, Chen TH-H, Liu T-Y, Chiu H-M, Chang C-C, Wang H-P, Wu M-S, Chiang H, Wu M-C, et al. A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures. Helicobacter. 2006;11(5):418–24. doi:https://doi.org/10.1111/j.1523-5378.2006.00432.x
   PubMed Web of Science ®Google Scholar
• Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54(6):764–8. doi:https://doi.org/10.1136/gut.2004.055400
   PubMed Web of Science ®Google Scholar
• Hamashima C, Sasazuki S, Inoue M, Tsugane S, JPHC Study Group. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests. BMC Cancer. 2017;17(1):183. doi:https://doi.org/10.1186/s12885-017-3173-0
   PubMedGoogle Scholar
• Kakiuchi T, Matsuo M, Endo H, Nakayama A, Sato K, Takamori A, Sasaki K, Takasaki M, Hara M, Sakata Y, et al. A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. J Gastroenterol. 2019;54(8):699–707. doi:https://doi.org/10.1007/s00535-019-01559-9
   PubMedGoogle Scholar
• Lee Y-C, Chen TH-H, Chiu H-M, Shun C-T, Chiang H, Liu T-Y, Wu M-S, Lin J-T. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut. 2013;62(5):676–82. doi:https://doi.org/10.1136/gutjnl-2012-302240
   PubMed Web of Science ®Google Scholar
• Mason J, Axon ATR, Forman D, Duffett S, Drummond M, Crocombe W, Feltbower R, Mason S, Brown J, Moayyedi P, Leeds HELP Study Group, et al. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Aliment Pharmacol Ther. 2002;16(3):559–68. doi:https://doi.org/10.1046/j.1365-2036.2002.01204.x
   PubMedGoogle Scholar
• Mason JM, Moayyedi P, Young PJ, Duffett S, Crocombe W, Drummond MF, Axon ATR, For the Leeds H. pylori Study Group. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group. Int J Technol Assess Health Care. 1999;15(4):649–60. doi:https://doi.org/10.1017/S0266462399015445
   PubMedGoogle Scholar
• Leung WK, Wu M-s, Kakugawa Y, Kim JJ, Yeoh K-g, Goh KL, Wu K-c, Wu D-c, Sollano J, Kachintorn U, Asia Pacific Working Group on Gastric Cancer, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87. doi:https://doi.org/10.1016/S1470-2045(08)70072-X
   PubMed Web of Science ®Google Scholar
• Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006;12(30):4873–4.
   PubMed Web of Science ®Google Scholar
• Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: is it needed? Gastrointest Endosc. 2016;84(1):18–28. doi:https://doi.org/10.1016/j.gie.2016.02.028
   PubMed Web of Science ®Google Scholar
• Vakil N, Rhew D, Soll A, Ofman JJ. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori. Am J Gastroenterol. 2000;95(7):1691–1698. doi:https://doi.org/10.1111/j.1572-0241.2000.02193.x
   PubMedGoogle Scholar
• Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen. 2004;11(3):141–7. doi:https://doi.org/10.1258/0969141041732184
   PubMed Web of Science ®Google Scholar
• Holleczek B, Schottker B, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: results from the prospective population-based ESTHER cohort study. Int J Cancer. 2020;146(10):2773–2783. doi:https://doi.org/10.1002/ijc.32610
   PubMed Web of Science ®Google Scholar
• Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006;9(4):245–53. doi:https://doi.org/10.1007/s10120-006-0397-0
   PubMedGoogle Scholar
• Castro C, Dinis-Ribeiro M, Rodrigues ANG, Calheiros T, Santos J, Pereira P, Ramos M, Cunha H, Andrade M, Costa A, et al. Western long-term accuracy of serum pepsinogen-based gastric cancer screening. Eur J Gastroenterol Hepatol. 2018;30(3):274–277.
   PubMedGoogle Scholar
• Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol. 2002;37(7):785–791. doi:https://doi.org/10.1080/gas.37.7.785.791
   PubMedGoogle Scholar
• Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis. 2007;8(1):15–22. doi:https://doi.org/10.1111/j.1443-9573.2007.00271.x
   PubMedGoogle Scholar
• Shen M, Wang H, Wei K, Zhang J, You C. Five common tumor biomarkers and CEA for diagnosing early gastric cancer: a protocol for a network meta-analysis of diagnostic test accuracy. Medicine (Baltimore). 2018;97(19):e0577. doi:https://doi.org/10.1097/MD.0000000000010577
   PubMedGoogle Scholar
• Chae H-D, Kim I-H, Lee GH, Shin I-H, Suh H-S, Jeon C-H. Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. Am J Clin Pathol. 2013;140(2):209–14. doi:https://doi.org/10.1309/AJCPOHXRM5IYXVOC
   PubMedGoogle Scholar
• Chen X-Z, Zhang W-K, Yang K, Wang L-L, Liu J, Wang L, Hu J-K, Zhang B, Chen Z-X, Chen J-P, et al. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol Biol Rep. 2012;39(9):9031–9. doi:https://doi.org/10.1007/s11033-012-1774-x
   PubMedGoogle Scholar
• Chen X-Z, Chen H, Castro FA, Hu J-K, Brenner H. Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine (Baltimore). 2015;94(20):e792. doi:https://doi.org/10.1097/MD.0000000000000792
   PubMed Web of Science ®Google Scholar
• Chen XZ, Wang R, Hu JK. Hepatitis B virus infection and gastric cancer risk: pitfalls in the potential association. Br J Cancer. 2015;112(11):1844. doi:https://doi.org/10.1038/bjc.2015.161
   PubMedGoogle Scholar
• Wang H, Chen X-L, Liu K, Bai D, Zhang W-H, Chen X-Z, Hu J-K, SIGES Research Group. Associations between gastric cancer risk and virus infection other than Epstein-Barr virus: a systematic review and meta-analysis based on epidemiological studies. Clin Transl Gastroenterol. 2020;11(7):e00201. doi:https://doi.org/10.14309/ctg.0000000000000201
   PubMedGoogle Scholar